Adverse reactions to cosmetics reported to the Chongqing adverse drug reaction monitoring centre system in China

被引:2
|
作者
Wang, Sha [1 ]
Jiang, Yang [1 ]
Lyu, Jing [1 ,2 ]
Li, Jiajia [1 ]
Diao, Qingchun [1 ]
机构
[1] Chongqing Hosp Tradit Chinese Med, Dept Dermatol, Chongqing, Peoples R China
[2] Chongqing Hosp Tradit Chinese Med, Dept Dermatol, 40 Daomenkou St, Chongqing, Peoples R China
关键词
adverse reaction; allergy; cosmetic adverse reactions; CONTACT-DERMATITIS; HAIR DYE; SKIN;
D O I
10.1111/cod.14248
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Background: Cosmetic adverse reactions (CARs) are becoming widespread in China. However, a comprehensive analysis of data is lacking. Objective: To analyse the clinical characteristics of patients with reported adverse reactions to cosmetics in Chongqing, China. Methods: Cases with CARs reported to the Chongqing Adverse Drug Reaction Monitoring Centre System from 2017 to 2021 were analysed. Results: A total of 23 245 cases were identified, of which 94.5% were women. Contact dermatitis (84.3%) was the most common diagnosis of CARs, followed by acne (3.1%). The most frequently reported clinical signs were erythema (70.1%), followed by papules (35.5%). The majority of CARs were reported to be due to ordinary cosmetics (87.9%), of which 81.0% were skin care products and 7.1% were makeup products. Cosmetics with special functions constituted 12.2%, of these, skin whitening (54.0%) and sunscreen (28.0%) products were most frequently reported. Conclusion: Our results suggest that adverse reactions to cosmetics are of concern in China, and dermatologists should actively identify and diagnose CARs. In addition, we should establish a convenient and effective model for collecting, reporting, and evaluating CARs.
引用
收藏
页码:201 / 205
页数:5
相关论文
共 50 条
  • [1] Avoidability of Adverse Drug Reactions Spontaneously Reported to a French Regional Drug Monitoring Centre
    Annie Pierre Jonville-Béra
    Hassan Saissi
    Lamiae Bensouda-Grimaldi
    Frederique Beau-Salinas
    Haware Cissoko
    Bruno Giraudeau
    Elisabeth Autret-Leca
    [J]. Drug Safety, 2009, 32 : 429 - 440
  • [2] Avoidability of Adverse Drug Reactions Spontaneously Reported to a French Regional Drug Monitoring Centre
    Jonville-Bera, Annie Pierre
    Saissi, Hassan
    Bensouda-Grimaldi, Lamiae
    Beau-Salinas, Frederique
    Cissoko, Haware
    Giraudeau, Bruno
    Autret-Leca, Elisabeth
    [J]. DRUG SAFETY, 2009, 32 (05) : 429 - 440
  • [3] Adverse Drug Reactions Due to Cosmetics Notified by ADR Monitoring Centre in a Tertiary Care Hospital
    Manjhi, P. K.
    Dikshit, H.
    Mohan, L.
    Mishra, H.
    Kumar, M.
    Dokania, S.
    [J]. DRUG SAFETY, 2016, 39 (10) : 999 - 999
  • [4] Adverse Cosmetic Reactions in a Pediatric Population Reported to the Chongqing Drug Administration in China From 2017 to 2021
    Wang, Sha
    Lyu, Jing
    Jiang, Yang
    Li, Jiajia
    Diao, Qingchun
    [J]. DERMATITIS, 2024, 35 (04) : 361 - 365
  • [5] Surveillance of adverse drug reactions at an adverse drug reaction monitoring centre in Central India: a 7-year surveillance study
    Sharma, Megha
    Baghel, Ruchi
    Thakur, Sunil
    Adwal, Sandeep
    [J]. BMJ OPEN, 2021, 11 (10):
  • [6] An overview of adverse drug reaction monitoring in China
    Zhou Y.
    Miller V.
    Hogan M.
    Callahan L.
    [J]. International Journal of Pharmaceutical Medicine, 2006, 20 (2): : 79 - 85
  • [7] Application of biclustering algorithm in adverse drug reaction monitoring system of China
    Zhu, Tiantian
    Zhang, Yuan
    Ye, Xiaofei
    Hou, Yongfang
    Liu, Jia
    Shi, Wentao
    Xu, Jinfang
    Guo, Xiaojing
    He, Jia
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 (11) : 1257 - 1264
  • [8] EVALUATION OF ADVERSE DRUG REACTION (ADR) MONITORING AND REPORTING SYSTEM IN CHINA
    Tang, J.
    Shao, R.
    Lin, F. J.
    Gao, X.
    [J]. VALUE IN HEALTH, 2014, 17 (07) : A791 - A791
  • [9] ADVERSE REACTIONS TO ANTIHYPERTENSIVE DRUGS, REPORTED TO THE SWEDISH-ADVERSE-DRUG-REACTION-COMMITTEE
    BOMAN, G
    [J]. ACTA MEDICA SCANDINAVICA, 1979, : 25 - 27
  • [10] Adverse Drug Reaction Monitoring at a Regional Pharmacovigilance Centre (BPKIHS)
    Rauniar, G. P.
    Panday, D. R.
    [J]. DRUG SAFETY, 2016, 39 (10) : 1038 - 1038